Linked Data API

Show Search Form

Search Results

431988
registered interest false more like this
date less than 2015-11-24more like thismore than 2015-11-24
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Human Papillomavirus: Vaccination remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what estimate he has made of the (a) reduction in cases of and deaths from human pappillomavirus (HPV) as a result of the introduction of the HPV vaccine to the UK schedule in 2008, (b) number of HPV vaccinations administered in each year since that programme began and (c) cost of delivering that programme in each year since 2008. more like this
tabling member constituency Denton and Reddish more like this
tabling member printed
Andrew Gwynne more like this
uin 17428 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-12-02more like thismore than 2015-12-02
answer text <p>HPV vaccination will eventually prevent hundreds of deaths due to cervical cancer every year. Public Health England (PHE) expect the major benefit of the vaccination programme, i.e. a decrease in cervical cancer, which peaks in women between 25 and 50; will be seen in some years’ time.</p><br /><p>Table 1: Number of HPV vaccine doses given for the academic years 2008/09 to 2013/14.</p><table><tbody><tr><td><p>Academic Year</p></td><td><p>Total doses given</p></td></tr><tr><td><p>2008/09 -2010/11<sup>1</sup> (routine and catch-up cohorts*)</p></td><td><p>5,319,058<sup>$</sup></p></td></tr><tr><td><p>2011/12<sup>2</sup> (routine only) <br></p></td><td><p>784,831</p></td></tr><tr><td><p>2012/13<sup>3</sup> (routine only) <br></p></td><td><p>766,832</p></td></tr><tr><td><p>2013/14<sup>4</sup> (routine only) <br></p></td><td><p>762,038</p></td></tr><tr><td><p>2014/15 (routine only) <br></p></td><td><p>Not available</p></td></tr></tbody></table><br /><p>*Routine cohort are school Yr8 females (aged 12-13 years) in academic years 2008/09, 2009/10, 2010/11) and catch-up cohorts are females born between 1/9/1990 and 31/8/1995. <sup>$</sup> Data for 2008/09, 2009/10 and 2010/11 are combined as these years had both routine and catch-up cohorts targeted and include some ‘mop-up’ vaccinations for eligible females receiving vaccine(s) after the academic year they first became eligible for vaccination.</p><br /> <br /><p>Table 2. The cost of delivering the HPV programme since 2008.</p><table><tbody><tr><td><p>Financial year</p></td><td><p>Estimated total programme costs</p></td></tr><tr><td><p>2008/09</p></td><td><p>£51 million</p></td></tr><tr><td><p>2009/10</p></td><td><p>£114 million (includes catch up campaign)</p></td></tr><tr><td><p>2010/11</p></td><td><p>£40 million</p></td></tr><tr><td><p>2011/12</p></td><td><p>£27 million (change in dosage schedule)</p></td></tr><tr><td><p>2012/13</p></td><td><p>£24 million</p></td></tr><tr><td><p>2013/14</p></td><td><p>£28.2 million</p></td></tr><tr><td><p>2014/15</p></td><td><p>£16.3 million (change from 3 to 2 doses)</p></td></tr></tbody></table><p><em></em></p><p>These are the estimated full programme costs (including the cost of the vaccine) for England, inclusive of VAT.</p><br /><p><strong></strong></p><p><strong><br> </strong></p><p><strong></strong></p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-12-02T18:04:42.503Zmore like thismore than 2015-12-02T18:04:42.503Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1506
label Biography information for Andrew Gwynne more like this